A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies
NCT03980821
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Malignancies
Interventions
DRUG:
AZD4635
Sponsor
AstraZeneca